Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
	Jan. 30, 2021 USD ($)	Feb. 01, 2020 USD ($)
Operating activities
Net (loss) income	$ (65,649)	$ 30,396
Add (deduct) items not affecting operating cash flows:
Adjustment to Tax Receivable Agreement Liability	(2,320)	(55,953)
Impairment of goodwill and intangible assets	13,848	19,491
Impairment of long-lived assets	13,026	818
Depreciation and amortization	6,898	9,602
Provision for bad debt	2,194	(51)
Loss on disposal of property and equipment		128
Amortization of deferred financing costs	674	554
Deferred income taxes	1,687	101
Share-based compensation expense	1,275	2,033
Capitalized PIK Interest	348
Other, net		(304)
Changes in assets and liabilities:
Receivables, net	6,594	(2,577)
Inventories	(1,823)	5,252
Prepaid expenses and other current assets	533	2,942
Accounts payable and accrued expenses	(6,563)	7,606
Other assets and liabilities	4,207	(3,219)
Net cash (used in) provided by operating activities	(25,071)	16,819
Investing activities
Payments for capital expenditures	(3,497)	(4,523)
Net cash used in investing activities	(3,497)	(4,523)
Financing activities
Proceeds from borrowings under the Revolving Credit Facilities	250,398	310,434
Repayment of borrowings under the Revolving Credit Facilities	(237,722)	(301,727)
Proceeds from borrowings under the Revolving Credit Facilities - Acquired Businesses		11,761
Repayment of borrowings under the Revolving Credit Facilities - Acquired Businesses		(29,410)
Repayment of borrowings under the Term Loan Facilities		(2,750)
Proceeds from borrowings under the Third Lien Credit Facility	20,000
Tax withholdings related to restricted stock vesting	(222)	(321)
Proceeds from stock option exercises, restricted stock vesting, and issuance of common stock under employee stock purchase plan	48	35
Financing fees	(715)	(13)
Net cash provided by (used in) financing activities	31,787	(11,991)
Increase in cash, cash equivalents, and restricted cash	3,219	305
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(7)	(20)
Cash, cash equivalents, and restricted cash, beginning of period	646	361
Cash and cash equivalents, end of period	3,858	646
Less: restricted cash at end of period	81	180
Cash and cash equivalents	3,777	466
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	3,136	4,195
Cash payments for income taxes, net of refunds	(113)	(13)
Supplemental Disclosures of Non-Cash Investing and Financing Activities
Capital expenditures in accounts payable and accrued liabilities	92	$ 494
Deferred financing fees in accrued liabilities and debt	$ 650